Research
Library

Peer-reviewed research on exosome biology, clinical applications, compounding pharmacy, and longevity science. Curated for licensed practitioners and biohacking coaches.

Educational Disclaimer: This library is curated for licensed medical professionals and is for informational purposes only. Inclusion of a study does not constitute endorsement of clinical application. All citations link directly to peer-reviewed sources on PubMed or publisher websites. The evidence base for many regenerative applications is still maturing; practitioners should apply professional judgment and consult current FDA guidance.

Researcher in a white lab coat and gloves using a pipette at a laboratory bench beside a microscope and sample racks
Fig. 1 | A researcher pipetting samples at a laboratory bench.Image: Rhoda Baercredit

Exosome Biology and Mechanism

Foundational research establishing the biological properties, characterization methods, and therapeutic potential of MSC-derived exosomes. These references provide the mechanistic basis for clinical research across all application areas.

Clinical applications of stem cell-derived exosomes.

Tan F, et al. Signal Transduction and Targeted Therapy. Jan 2024;9:17.

View Source →
Clinical ImplicationComprehensive review of MSC-derived exosome clinical applications demonstrating non-immunogenicity, scalability advantages over whole-cell therapies, and growing IND pipeline.

Exosome Source Matters: A Comprehensive Review from the Perspective of Diverse Cellular Origins.

Chen Y, et al. Pharmaceutics. Feb 2025;17(2):147.PMC11858990

View Source →
Clinical ImplicationEstablishes that cell source determines exosome cargo composition and thus biological effects, making sourcing documentation a critical procurement consideration.

Clinical Frontiers of Exosome Research: A Comprehensive Analysis of Human Trials.

Mohan S, et al. Journal of Pharmacology and Pharmacotherapeutics. 2025.

View Source →
Clinical ImplicationReview of 90 published human clinical studies of exosomes, spanning diagnostic, therapeutic and regenerative applications.

Therapeutic potential of mesenchymal stem cell-derived exosomes for regenerative medicine applications.

Roszkowski S. Clinical and Experimental Medicine. 2024;24(1):46.PMC10907468

View Source →
Clinical ImplicationSystematic review of MSC-derived exosome applications in tissue repair and inflammatory modulation across bone marrow, adipose, and umbilical cord sources.

Dermatological Applications

Research examining exosome and biologic applications in skin biology, wound healing, and dermatological procedures. The evidence base is predominantly preclinical and early-phase; large controlled trials in aesthetic dermatology are still maturing.

Extracellular Vesicles Derived From Mesenchymal Stem Cells (MSC) in Regenerative Medicine: Applications in Skin Wound Healing.

Casado-Díaz A, et al. Frontiers in Bioengineering and Biotechnology. 2020;8:146.PMC7062641

View Source →
Clinical ImplicationMSC-derived EVs promote wound healing through paracrine signaling, with evidence for fibroblast proliferation and keratinocyte migration enhancement in wound models.

Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies.

Akers JC, et al. Journal of Neuro-Oncology. 2013;113(1):1-11.PMC5533094

View Source →
Clinical ImplicationFoundational biogenesis reference relevant to understanding the mechanistic diversity of EV subtypes used in dermatological research protocols.

Mesenchymal stem cell derived-exosomes: a modern approach in translational medicine.

Nikfarjam S, et al. Journal of Translational Medicine. 2020;18(1):449.PMC7691969

View Source →
Clinical ImplicationTranslational review covering MSC exosome preparation methods, characterization standards, and early clinical observations across tissue types including skin.

Hair Restoration and Alopecia

Research on PRP and emerging exosome applications in hair follicle biology, androgenetic alopecia, and dermal papilla cell signaling. PRP has the most established human clinical trial support; exosome research in this area is growing but predominantly preclinical.

Labeled medical illustration of a hair follicle in skin, showing the hair shaft, sebaceous gland, arrector pili muscle, hair bulb, matrix and papilla
Fig. 2 | Anatomy of the hair follicle.Image: BruceBlauscredit

The Efficacy of Platelet-Rich Plasma in the Field of Hair Restoration and Facial Aesthetics: A Systematic Review and Meta-analysis.

Gupta AK, Versteeg SG, et al. Journal of Cutaneous Medicine and Surgery. 2019;23(2):185-203.

View Source →
Clinical ImplicationSystematic review and meta-analysis supporting PRP efficacy in androgenetic alopecia, providing the established clinical baseline against which exosome approaches are compared.

Wnt signaling in skin development, homeostasis, and disease.

Lim X, Nusse R. Cold Spring Harbor Perspectives in Biology. 2013;5(2):a008029.PMC3552514

View Source →
Clinical ImplicationMechanistic reference for the Wnt/beta-catenin pathway in follicle cycling, which MSC-derived exosome cargo components are proposed to modulate in hair restoration research.

Systematic review of exosome treatment in hair restoration: Preliminary evidence, safety, and future directions.

Gupta AK, Wang T, Rapaport JA. Journal of Cosmetic Dermatology. 2023;22(9):2424-2433.

View Source →
Clinical ImplicationDocuments the importance of adipose and umbilical cord MSC sources for dermal papilla cell studies, relevant to product sourcing decisions in hair restoration protocols.

Sports Medicine and Orthopedic Applications

Research on PRP and regenerative biologic applications in tendon, ligament, and joint biology. PRP has the longest orthopedic clinical track record. MSC-derived exosomes are an emerging area with growing preclinical support in musculoskeletal research.

Platelet Rich Plasma: a short overview of certain bioactive components.

Pavlovic V, et al. Open Medicine. 2016;11(1):242-247.PMC5329835

View Source →
Clinical ImplicationOverview of PRP growth factor bioactivities relevant to musculoskeletal applications, including PDGF, TGF-beta, and VEGF release mechanisms.

Sports medicine applications of platelet rich plasma.

Mishra A, et al. Current Pharmaceutical Biotechnology. 2012;13(7):1185-1195.

View Source →
Clinical ImplicationEarly clinical applications of PRP in sports medicine establishing the foundational rationale for regenerative platelet concentrates in orthopedic protocols.

Platelet-rich plasma: the PAW classification system.

DeLong JM, et al. Arthroscopy. 2012;28(7):998-1009.

View Source →
Clinical ImplicationProposes a standardized classification for PRP preparations (platelet concentration, activation method, white blood cell content) addressing the variability problem in PRP research.

Platelet-Rich Plasma: Intra-Articular Knee Injections Produced Favorable Results on Degenerative Cartilage Lesions.

Kon E, et al. Knee Surgery, Sports Traumatology, Arthroscopy. 2010;18(4):472-479.

View Source →
Clinical ImplicationProspective clinical study of PRP intra-articular injections demonstrating improvement in knee pain and function scores in degenerative conditions.

Compounding Pharmacy and Regulatory Context

Reference material on 503A/503B compounding regulatory frameworks, cGMP standards, and the FDA oversight structure for biologics and compounded preparations relevant to regenerative medicine supply chains.

Guidance for Industry: Current Good Manufacturing Practice Requirements for Combination Products.

FDA. FDA Guidance Documents. 2015 (Updated 2017).

View Source →
Clinical ImplicationCore regulatory reference for cGMP manufacturing standards applicable to combination biologic/device products in the exosome supply chain.

Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use; Guidance for Industry and FDA Staff (supersedes the withdrawn 2014 adipose tissue draft guidance).

FDA. FDA Guidance Documents. July 2020.

View Source →
Clinical ImplicationCritical regulatory reference for practitioners sourcing adipose-derived biologics, clarifying the 21 CFR Part 1271 HCT/P criteria and enforcement priorities.

Longevity Medicine and Functional Biology

Research relevant to biohacking coaches and longevity practitioners, covering NAD+ metabolism, hallmarks of aging, cellular senescence, and the mechanistic rationale for regenerative interventions in functional medicine contexts.

The Hallmarks of Aging.

Lopez-Otin C, et al. Cell. 2013;153(6):1194-1217.

View Source →
Clinical ImplicationFoundational framework defining 9 hallmarks of aging (genomic instability, telomere attrition, etc.) that underpin the scientific rationale for longevity medicine and regenerative interventions.

NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR.

Yoshino J, et al. Cell Metabolism. 2018;27(3):513-528.

View Source →
Clinical ImplicationReviews NAD+ precursor biology (NMN and NR), mitochondrial function, and the scientific basis for NAD+ supplementation in longevity and functional medicine protocols.

Senolytic drugs: from discovery to translation.

Kirkland JL, Tchkonia T. Journal of Internal Medicine. 2020;288(5):518-536.

View Source →
Clinical ImplicationTranslational review of senolytic agents (dasatinib, quercetin) for selective clearance of senescent cells, a major focus area in biohacking and longevity medicine practice.

Image credits

  1. Fig. 1Rhoda Baer, National Cancer Institute, Wikimedia Commons (NCI Visuals Online), Public domain. ↩
  2. Fig. 2BruceBlaus (Blausen.com staff, 2014, Medical gallery of Blausen Medical 2014, WikiJournal of Medicine 1(2), doi:10.15347/wjm/2014.010), Wikimedia Commons, CC BY 3.0. ↩

Source the Biologics Behind the Research

ExaVeyra Sciences supplies NPI-verified practitioners with cGMP exosome formulations and devices, and refers prescribers to our 503A pharmacy partner for compounded preparations dispensed on a patient-specific prescription.